Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018–a cohort study in Denmark-Reference-Cited by-同舟云学术

Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018–a cohort study in Denmark

Published:2023-09-12 Issue:12 Volume:62 Page:1672-1679
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Meldgaard Peter¹^ORCID,Kristensen Michael²^ORCID,Conte Simona³^ORCID,Kaae Andersen Klaus⁴^ORCID,Jovanovic Aleksander⁵,Meldgaard Ebbe⁶^ORCID

Affiliation:

1. Institute for Clinical Medicine, Department of Oncology, Aarhus University Hospital, Denmark

2. AstraZeneca, Copenhagen, Denmark

3. AstraZeneca, Stockholm, Sweden

4. Omicron ApS, Copenhagen, Denmark

5. Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark

6. Department of Oncology, Aarhus University Hospital, Denmark

Funder

AstraZeneca AB

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2254474

Reference31 articles.

1. Globocan [Internet]. GLOBOCAN 2020 updated 2021 March; [cited 2023 April 3]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/208-denmark-fact-sheets.pdf.

2. NORDCAN AotNCR [Internet]. NORDCAN Association of the Nordic Cancer Registries; 2022. IARC 1965–2023. [Cited 2023 April 3] Available from: https://nordcan.iarc.fr/en.

3. Mortality and survival of lung cancer in Denmark: Results from the Danish Lung Cancer Group 2000–2012

4. NORDCAN – a Nordic tool for cancer information, planning, quality control and research

5. The Effect of Advances in Lung-Cancer Treatment on Population Mortality

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study;Cancers;2024-07-19